Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies

[1]  L. Tranebjærg.  Deafness-Dystonia-Optic Neuronopathy Syndrome , 2013 .

[2]  D. Turnbull,et al.  Treatment for mitochondrial disorders. , 2012, The Cochrane database of systematic reviews.

[3]  G. Holder,et al.  Tobacco optic neuropathy (TON) – the historical and present concept of the disease , 2011, Acta ophthalmologica.

[4]  N. Newman,et al.  Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. , 2011, Ophthalmology.

[5]  P. Chinnery,et al.  OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy , 2010, Brain : a journal of neurology.

[6]  Ester Perales-Clemente,et al.  Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task? , 2010, Nucleic Acids Res..

[7]  P. Chinnery,et al.  How can we treat mitochondrial encephalomyopathies? approaches to therapy , 2008, Neurotherapeutics.

[8]  M. King,et al.  What limits the allotopic expression of nucleus-encoded mitochondrial genes? The case of the chimeric Cox3 and Atp6 genes. , 2011, Mitochondrion.

[9]  A. Martinuzzi,et al.  Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. , 2011, Brain : a journal of neurology.

[10]  Stéphane Schmucker,et al.  Understanding the Molecular Mechanisms of Friedreich′s Ataxia to Develop Therapeutic Approaches , 2010 .

[11]  Pete A. Williams,et al.  Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. , 2010, Brain : a journal of neurology.

[12]  A. Echaniz-Laguna,et al.  POLG1 variations presenting as multiple sclerosis. , 2010, Archives of neurology.

[13]  Yong-Gang Yao,et al.  No association between the SNPs (rs3749446 and rs1402000) in the PARL gene and LHON in Chinese patients with m.11778G>A , 2010, Human Genetics.

[14]  Robert W. Taylor,et al.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. , 2010, Ophthalmology.

[15]  M. Zeviani,et al.  OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. , 2010, Ophthalmology.

[16]  M. Huizing,et al.  A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3 , 2010, Development.

[17]  G. Cantalupo,et al.  Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. , 2010, Brain : a journal of neurology.

[18]  D. Milea,et al.  Never too old to harbour a young man's disease? , 2010, British Journal of Ophthalmology.

[19]  V. Carelli,et al.  Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber’s hereditary optic neuropathy , 2010, Documenta Ophthalmologica.

[20]  C. E. Larkins,et al.  Mitochondrial retention of Opa1 is required for mouse embryogenesis , 2010, Mammalian Genome.

[21]  Mark Ellisman,et al.  Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma , 2010, Molecular vision.

[22]  N. Newman,et al.  The neuro-ophthalmology of mitochondrial disease. , 2010, Survey of ophthalmology.

[23]  T. Yagi,et al.  Successful Amelioration of Mitochondrial Optic Neuropathy Using the Yeast NDI1 Gene in a Rat Animal Model , 2010, PloS one.

[24]  M. Vaphiades,et al.  Drug-induced optic neuropathy-TB or not TB. , 2010, Survey of ophthalmology.

[25]  D. Mackey,et al.  Genetics: Optic nerve genetics—more than meets the eye , 2010, Nature Reviews Neurology.

[26]  T. Stemmler,et al.  Frataxin and Mitochondrial FeS Cluster Biogenesis* , 2010, The Journal of Biological Chemistry.

[27]  E. Bartnik,et al.  Genotype-phenotype correlations in Leber hereditary optic neuropathy. , 2010, Biochimica et biophysica acta.

[28]  S. Dimauro,et al.  Therapeutic prospects for mitochondrial disease. , 2010, Trends in molecular medicine.

[29]  Hans-Peter Braun,et al.  Structure and function of mitochondrial supercomplexes. , 2010, Biochimica et biophysica acta.

[30]  W. Gahl,et al.  OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. , 2010, Molecular genetics and metabolism.

[31]  G. Ying,et al.  Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis , 2010, Annals of neurology.

[32]  P. Chinnery,et al.  OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules , 2010, Human molecular genetics.

[33]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[34]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[35]  S. Park,et al.  Antituberculosis medication as a possible epigenetic factor of Leber's hereditary optic neuropathy , 2010, Clinical & experimental ophthalmology.

[36]  Yusuke Nakamura,et al.  Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand , 2010, Human Genetics.

[37]  N. Miller,et al.  Sustained neuroprotection after a single intravitreal injection of PGJ2 in a rodent model of NAION , 2010 .

[38]  F. Rahman,et al.  Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy , 2010, Molecular vision.

[39]  M. Golomb,et al.  Is it ADEM, POLG, or both? , 2010, Archives of neurology.

[40]  Chulhee Choi,et al.  Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation , 2010, Cellular and Molecular Life Sciences.

[41]  P. Matarrese,et al.  Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients , 2010, Antiviral therapy.

[42]  D. Milea,et al.  Selective wavelength pupillometry in Leber hereditary optic neuropathy , 2010, Clinical & experimental ophthalmology.

[43]  Y. Yang,et al.  Chloramphenicol Causes Mitochondrial Stress, Decreases ATP Biosynthesis, Induces Matrix Metalloproteinase-13 Expression, and Solid-Tumor Cell Invasion , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Xueshan Xiao,et al.  Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese , 2010, Molecular vision.

[45]  Patrick F Chinnery,et al.  Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease , 2010, Nature.

[46]  P. Heiduschka,et al.  Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy. , 2010, Investigative ophthalmology & visual science.

[47]  D. Bonneau,et al.  Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity. , 2010, Mitochondrion.

[48]  G. Savini,et al.  Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. , 2010, Ophthalmology.

[49]  R. Ritch,et al.  Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. , 2010, Investigative ophthalmology & visual science.

[50]  J. Heymann,et al.  OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation , 2010, Human molecular genetics.

[51]  D. Turnbull,et al.  Multi-system neurological disease is common in patients with OPA1 mutations , 2010, Brain : a journal of neurology.

[52]  M. Mancuso,et al.  Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy , 2010, Neuromuscular Disorders.

[53]  P. Reddy,et al.  Is multiple sclerosis a mitochondrial disease? , 2009, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[54]  M. Larsen,et al.  Axonal loss occurs early in dominant optic atrophy , 2009, Acta ophthalmologica.

[55]  F. Verde,et al.  Microtubule-dependent spatial organization of mitochondria in fission yeast. , 2010, Methods in cell biology.

[56]  S. Di Giovanni,et al.  Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. , 2010, Investigative ophthalmology & visual science.

[57]  J. Gal,et al.  Mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2010, Biochimica et biophysica acta.

[58]  E. Rugarli,et al.  Emerging roles of mitochondrial proteases in neurodegeneration. , 2010, Biochimica et biophysica acta.

[59]  J. Seo,et al.  Comparison of retinal nerve fibre layers between 11778 and 14484 mutations in Leber's hereditary optic neuropathy , 2010, Eye.

[60]  Ian A Sigal,et al.  3D morphometry of the human optic nerve head. , 2010, Experimental eye research.

[61]  K. Ray,et al.  Molecular complexity of primary open angle glaucoma: current concepts , 2009, Journal of Genetics.

[62]  E. Holme,et al.  Ophthalmological findings in children and young adults with genetically verified mitochondrial disease , 2009, British Journal of Ophthalmology.

[63]  P. Chinnery,et al.  The inheritance of pathogenic mitochondrial DNA mutations , 2009, Biochimica et biophysica acta.

[64]  S. Dimauro,et al.  A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases. , 2009, Biochimica et biophysica acta.

[65]  V. Kostic,et al.  Brain white matter 1 H MRS in Leber optic neuropathy mutation carriers. , 2009, Acta neurologica Belgica.

[66]  Anna Ghelli,et al.  The Background of Mitochondrial DNA Haplogroup J Increases the Sensitivity of Leber's Hereditary Optic Neuropathy Cells to 2,5-Hexanedione Toxicity , 2009, PloS one.

[67]  Jacqueline A Palace.  Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy , 2009, Journal of the Neurological Sciences.

[68]  A. Starr,et al.  Mutation of OPA1 gene causes deafness by affecting function of auditory nerve terminals , 2009, Brain Research.

[69]  D. Chan,et al.  Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases , 2009, Human molecular genetics.

[70]  Yuyu Song,et al.  Axonal Transport Defects in Neurodegenerative Diseases , 2009, The Journal of Neuroscience.

[71]  G. Lenaers,et al.  OPA1 functions in mitochondria and dysfunctions in optic nerve. , 2009, The international journal of biochemistry & cell biology.

[72]  Nektarios Tavernarakis,et al.  Prohibitin and mitochondrial biology , 2009, Trends in Endocrinology & Metabolism.

[73]  M. Votruba,et al.  Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy. , 2009, Investigative ophthalmology & visual science.

[74]  B. Müller-Myhsok,et al.  Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study , 2009, BMC Medical Genetics.

[75]  N. Newman.  Leber hereditary optic neuropathy: bad habits, bad vision? , 2009, Brain : a journal of neurology.

[76]  K. Ocorr,et al.  Heterozygous Mutation of Drosophila Opa1 Causes the Development of Multiple Organ Abnormalities in an Age-Dependent and Organ-Specific Manner , 2009, PloS one.

[77]  Y. Li,et al.  Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells , 2009, Nature.

[78]  J. Martinou,et al.  Role of mitofusin 2 mutations in the physiopathology of Charcot–Marie–Tooth disease type 2A , 2009, Experimental Neurology.

[79]  J. Montaner,et al.  OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRIAL TOXICITY IN PATIENTS RECEIVING HIV THERAPY , 2009, Neurology.

[80]  P. Chinnery,et al.  OPA1 increases the risk of normal but not high tension glaucoma , 2009, Journal of Medical Genetics.

[81]  P. Chinnery,et al.  Quality of life in patients with leber hereditary optic neuropathy. , 2009, Investigative ophthalmology & visual science.

[82]  Jin-wei Cheng,et al.  Meta-analysis of medical intervention for normal tension glaucoma. , 2009, Ophthalmology.

[83]  D. Milea,et al.  Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations , 2009, Human mutation.

[84]  Davide Pareyson,et al.  Diagnosis, natural history, and management of Charcot–Marie–Tooth disease , 2009, The Lancet Neurology.

[85]  P. Chinnery,et al.  Gene–environment interactions in Leber hereditary optic neuropathy , 2009, Brain : a journal of neurology.

[86]  Michael S. Lee,et al.  Another case of leber hereditary optic neuropathy in an octogenarian. , 2009, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[87]  D. Turnbull,et al.  OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. , 2009, Investigative ophthalmology & visual science.

[88]  P. Hanson,et al.  Edinburgh Research Explorer Mitochondrial Changes within Axons in Multiple Sclerosis Mitochondrial Changes within Axons in Multiple Sclerosis , 2022 .

[89]  R. Weinreb,et al.  Experimental detection of retinal ganglion cell damage in vivo. , 2009, Experimental eye research.

[90]  Ian A Sigal,et al.  Biomechanics of the optic nerve head. , 2009, Experimental eye research.

[91]  A. Munnich,et al.  TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy. , 2009, American journal of human genetics.

[92]  G. Savini,et al.  Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. , 2009, Investigative ophthalmology & visual science.

[93]  A. Toutain,et al.  Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect , 2009, Molecular vision.

[94]  J. Hwang,et al.  Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells. , 2009, Toxicology and applied pharmacology.

[95]  G. Egea,et al.  Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. , 2009, Molecular biology of the cell.

[96]  Jeong-Min Hwang,et al.  Early Stage Ethambutol Optic Neuropathy: Retinal Nerve Fiber Layer and Optical Coherence Tomography , 2009, European journal of ophthalmology.

[97]  D. Wallace,et al.  Heterozygous Mutation of Opa1 in Drosophila Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production , 2009, PloS one.

[98]  Mark Ellisman,et al.  Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. , 2009, Investigative ophthalmology & visual science.

[99]  S. Hayreh.  Ischemic optic neuropathy , 2009, Progress in Retinal and Eye Research.

[100]  P. Chinnery,et al.  Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy , 2008, Journal of Medical Genetics.

[101]  Mark Ellisman,et al.  Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells , 2007, Molecular vision.

[102]  J. D. Cascajosa,et al.  Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders , 2009 .

[103]  R. Penne.  Frontalis sling operation using silicone rod for the correction of ptosis in chronic progressive external ophthalmoplegia , 2009 .

[104]  M. Zeviani,et al.  Mitochondrial diseases: a cross-talk between mitochondrial and nuclear genomes. , 2009, Advances in experimental medicine and biology.

[105]  V. Felipo,et al.  Inherited neuromuscular diseases. Translation from pathomechanisms to therapies. , 2009, Advances in experimental medicine and biology.

[106]  D. Manners,et al.  Visual system involvement in patients with Friedreich's ataxia. , 2009, Brain : a journal of neurology.

[107]  M. Zeviani,et al.  Clinical and molecular features of mitochondrial DNA depletion syndromes , 2009, Journal of Inherited Metabolic Disease.

[108]  R. Weinreb,et al.  Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina , 2008, Molecular vision.

[109]  Eduardo Ruiz-Pesini,et al.  Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. , 2008, Human molecular genetics.

[110]  H. Bandelt,et al.  Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G-->a mutation. , 2008, American journal of human genetics.

[111]  Eun Ji Lee,et al.  Incidence and Clinical Features of Ethambutol-Induced Optic Neuropathy in Korea , 2008, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[112]  James G Fujimoto,et al.  Optical coherence tomography: a window into the mechanisms of multiple sclerosis , 2008, Nature Clinical Practice Neurology.

[113]  Christos Proukakis,et al.  Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms , 2008, The Lancet Neurology.

[114]  D. Turnbull,et al.  OPA1 IN MULTIPLE MITOCHONDRIAL DNA DELETION DISORDERS , 2008, Neurology.

[115]  A. Martinuzzi,et al.  Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids , 2008, Journal of neuroscience research.

[116]  P. Chinnery,et al.  Inherited mitochondrial optic neuropathies , 2008, Journal of Medical Genetics.

[117]  J. Christodoulou,et al.  Costeff optic atrophy syndrome: New clinical case and novel molecular findings , 2008, Journal of Inherited Metabolic Disease.

[118]  M. Bortolozzi,et al.  A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. , 2008, Human molecular genetics.

[119]  C. Mawrin,et al.  The G11778A LHON mutation does not enhance ethambutol cytotoxicity in a cybrid model. , 2008, Clinical neuropathology.

[120]  Mark Ellisman,et al.  Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. , 2008, Investigative ophthalmology & visual science.

[121]  P. Garcia-Filion,et al.  The syndrome of optic nerve hypoplasia , 2008, Current neurology and neuroscience reports.

[122]  M. Tarnopolsky.  The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. , 2008, Advanced drug delivery reviews.

[123]  J. Sahel,et al.  Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. , 2008, American journal of human genetics.

[124]  P. Chinnery,et al.  Pathogenic Mitochondrial DNA Mutations Are Common in the General Population , 2008, American journal of human genetics.

[125]  D. Mackey,et al.  The natural history of OPA1-related autosomal dominant optic atrophy , 2008, British Journal of Ophthalmology.

[126]  G. Swarup,et al.  Focus on molecules: optineurin. , 2008, Experimental eye research.

[127]  Amy Conger,et al.  Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. , 2008, Archives of neurology.

[128]  E. Müller,et al.  Characterization of OPA1 isoforms isolated from mouse tissues , 2008, Journal of neurochemistry.

[129]  A. Lee,et al.  You're too old for that. , 2008, Survey of ophthalmology.

[130]  R. Youle,et al.  Mitochondrial dynamics and apoptosis. , 2008, Genes & development.

[131]  P. Chinnery,et al.  Leber hereditary optic neuropathy presenting in a 75-year-old man. , 2008, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[132]  D. Milea,et al.  Hereditary optic neuropathies share a common mitochondrial coupling defect , 2008, Annals of neurology.

[133]  Guang-Yu Li,et al.  Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies , 2008, Journal of neurochemistry.

[134]  Amie J Dirks Naylor,et al.  Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy , 2008, Pharmacology.

[135]  Joan W. Miller.  Preliminary results of gene therapy for retinal degeneration. , 2008, The New England journal of medicine.

[136]  R. Lightowlers,et al.  Progress and prospects: gene therapy for mitochondrial DNA disease , 2008, Gene Therapy.

[137]  D. Wallace,et al.  Reversible optic neuropathy with OPA1 exon 5b mutation , 2008, Annals of neurology.

[138]  M. K. Walsh,et al.  In vivo time-lapse fluorescence imaging of individual retinal ganglion cells in mice , 2008, Journal of Neuroscience Methods.

[139]  D. Bonneau,et al.  MULTIPLE SCLEROSIS–LIKE DISORDER IN OPA1-RELATED AUTOSOMAL DOMINANT OPTIC ATROPHY , 2008, Neurology.

[140]  V. Carelli,et al.  Myelin, mitochondria, and autoimmunity , 2008, Neurology.

[141]  A. Torroni,et al.  Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus , 2008, Neurology.

[142]  M. Zeviani,et al.  155th ENMC workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands , 2008, Neuromuscular Disorders.

[143]  R. Schwarzenbacher,et al.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. , 2008, Brain : a journal of neurology.

[144]  Robert W. Taylor,et al.  Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. , 2008, Brain : a journal of neurology.

[145]  M. Zeviani.  OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. , 2008, Brain : a journal of neurology.

[146]  A. Martinuzzi,et al.  Protection against oxidant-induced apoptosis by exogenous glutathione in Leber hereditary optic neuropathy cybrids. , 2008, Investigative ophthalmology & visual science.

[147]  K. Khrapko.  Two ways to make an mtDNA bottleneck , 2008, Nature Genetics.

[148]  Jennifer R. Davies,et al.  A missense mutation in the murine Opa3 gene models human Costeff syndrome. , 2008, Brain : a journal of neurology.

[149]  R. Youle,et al.  OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. , 2008, Brain : a journal of neurology.

[150]  A. Quattrone,et al.  A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation , 2008, Journal of Neurology.

[151]  Robert W. Taylor,et al.  Prevalence of mitochondrial DNA disease in adults , 2008, Annals of neurology.

[152]  V. Sheffield,et al.  Evidence for a Novel X-Linked Modifier Locus for Leber Hereditary Optic Neuropathy , 2008, Ophthalmic genetics.

[153]  D. Wallace,et al.  The Molecular Mechanisms of OPA1-Mediated Optic Atrophy in Drosophila Model and Prospects for Antioxidant Treatment , 2008, PLoS genetics.

[154]  Caterina Tonon,et al.  Idebenone in Friedreich's ataxia. , 2008, Expert opinion on pharmacotherapy.

[155]  M. Cordeiro,et al.  Assessment of neuroprotection in the retina with DARC , 2008, Progress in brain research.

[156]  S. Dimauro,et al.  Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. , 2008, Archives of neurology.

[157]  David R Williams,et al.  In vivo imaging of the fine structure of rhodamine-labeled macaque retinal ganglion cells. , 2008, Investigative ophthalmology & visual science.

[158]  H. Smeets,et al.  X-Inactivation patterns in females harboring mtDNA mutations that cause Leber hereditary optic neuropathy. , 2007, Molecular vision.

[159]  Tae-Woo Kim,et al.  Stratus OCT in Dominant Optic Atrophy: Features Differentiating it From Glaucoma , 2007, Journal of glaucoma.

[160]  K. Shinoda,et al.  Woman with atypical unilateral Leber's hereditary optic neuropathy with visual improvement. , 2007, Clinical & experimental ophthalmology.

[161]  K. Fischbeck,et al.  Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial , 2007, The Lancet Neurology.

[162]  I. Boldogh,et al.  Mitochondria on the move. , 2007, Trends in cell biology.

[163]  H. Yatsuya,et al.  Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations. , 2007, Investigative ophthalmology & visual science.

[164]  P. Dorman,et al.  Homoplasmy, heteroplasmy, and mitochondrial dystonia , 2007, Neurology.

[165]  Yongge Zhao,et al.  Optineurin Negatively Regulates TNFα- Induced NF-κB Activation by Competing with NEMO for Ubiquitinated RIP , 2007, Current Biology.

[166]  A. Grzybowski.  Tobacco amblyopia: does it really exist? , 2007, Eye.

[167]  A. Solano,et al.  Molecular Genetics of a Patient with Mohr–Tranebjaerg Syndrome due to a New Mutation in the DDP1 Gene , 2007, NeuroMolecular Medicine.

[168]  Patrick F Chinnery,et al.  Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. , 2007, American journal of human genetics.

[169]  S. Ballinger,et al.  The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. , 2007, Mutation research.

[170]  P. Elliott,et al.  SIRT1 activation confers neuroprotection in experimental optic neuritis. , 2007, Investigative ophthalmology & visual science.

[171]  D. Birchall,et al.  PRIMARY SPINAL CORD NEURODEGENERATION IN LEBER HEREDITARY OPTIC NEUROPATHY , 2007, Neurology.

[172]  P. Chinnery,et al.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G. , 2007, American journal of human genetics.

[173]  L. Scorrano,et al.  A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis , 2007, Cell Death and Differentiation.

[174]  S. Muñoz,et al.  Respuesta a la idebenona asociada a multivitaminoterapia en neuropatía óptica hereditaria de Leber , 2007 .

[175]  Michael V. Boland,et al.  Risk factors and open-angle glaucoma: classification and application. , 2007, Journal of glaucoma.

[176]  H. Smeets,et al.  A MELAS-associated ND1 mutation causing leber hereditary optic neuropathy and spastic dystonia. , 2007, Archives of neurology.

[177]  Jennifer R. Davies,et al.  Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. , 2007, Human molecular genetics.

[178]  S. Dimauro,et al.  Mitochondrial Diseases: Therapeutic Approaches , 2007, Bioscience reports.

[179]  V. Carelli,et al.  Mitochondrial Optic Neuropathies: How Two Genomes may Kill the Same Cell Type? , 2007, Bioscience reports.

[180]  R Mark Payne,et al.  Mitochondrial protein import and human health and disease. , 2007, Biochimica et biophysica acta.

[181]  V. Mils,et al.  Effects of OPA1 mutations on mitochondrial morphology and apoptosis: Relevance to ADOA pathogenesis , 2007, Journal of cellular physiology.

[182]  H. Waterham,et al.  A lethal defect of mitochondrial and peroxisomal fission. , 2007, The New England journal of medicine.

[183]  K. Huoponen,et al.  Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland , 2007, European Journal of Human Genetics.

[184]  David A Mackey,et al.  Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. , 2007, American journal of ophthalmology.

[185]  D. Bonneau,et al.  Mitochondrial coupling defect in Charcot–Marie–Tooth type 2A disease , 2007, Annals of neurology.

[186]  N. Osborne,et al.  Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures , 2007, Vision Research.

[187]  V. Radha,et al.  A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. , 2007, Investigative ophthalmology & visual science.

[188]  M. Beal,et al.  Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders , 2007, Muscle & nerve.

[189]  W. Hauswirth,et al.  Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. , 2007, Archives of ophthalmology.

[190]  V. Tiranti,et al.  Depletion of mtDNA: syndromes and genes. , 2007, Mitochondrion.

[191]  S. Beck,et al.  A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. , 2006, Brain : a journal of neurology.

[192]  F. Violante,et al.  Grand Rounds: Could Occupational Exposure to n-Hexane and Other Solvents Precipitate Visual Failure in Leber Hereditary Optic Neuropathy? , 2006, Environmental health perspectives.

[193]  B. Barbiroli,et al.  Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 , 2007 .

[194]  Yongge Zhao,et al.  Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. , 2007, Current biology : CB.

[195]  Sa Tang,et al.  The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. , 2007, American journal of ophthalmology.

[196]  J. Wiggs.  Genetic etiologies of glaucoma. , 2007, Archives of ophthalmology.

[197]  W. Hauswirth,et al.  The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse. , 2007, Investigative ophthalmology & visual science.

[198]  A. Sadun,et al.  Linezolid-induced optic neuropathy: a mitochondrial disorder? , 2006, British Journal of Ophthalmology.

[199]  J. Keltner,et al.  Leber hereditary optic neuropathy possibly triggered by exposure to tire fire. , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[200]  G. Savini,et al.  Leber's hereditary optic neuropathy with childhood onset. , 2006, Investigative ophthalmology & visual science.

[201]  P. Lertrit,et al.  Mitochondrial DNA Haplogroup Distribution in Pedigrees of Southeast Asian G11778A Leber Hereditary Optic Neuropathy , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[202]  M. Votruba,et al.  Focus on molecules: the OPA1 protein. , 2006, Experimental eye research.

[203]  Z. Tong,et al.  A family with X‐linked optic atrophy linked to the OPA2 locus Xp11.4‐Xp11.2 , 2006, American journal of medical genetics. Part A.

[204]  D. Mokranjac,et al.  Structure and function of Tim14 and Tim16, the J and J‐like components of the mitochondrial protein import motor , 2006, The EMBO journal.

[205]  J. Haines,et al.  Distribution of Optineurin Sequence Variations in an Ethnically Diverse Population of Low-tension Glaucoma Patients From the United States , 2006, Journal of glaucoma.

[206]  S. Salamat,et al.  Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. , 2006, American journal of human genetics.

[207]  D. Mackey,et al.  The role of the Met98Lys optineurin variant in inherited optic nerve diseases , 2006, British Journal of Ophthalmology.

[208]  S. Sripriya,et al.  OPTN gene: profile of patients with glaucoma from India. , 2006, Molecular vision.

[209]  R. D'Hooge,et al.  Mitochondrial Rhomboid PARL Regulates Cytochrome c Release during Apoptosis via OPA1-Dependent Cristae Remodeling , 2006, Cell.

[210]  Sara Cipolat,et al.  OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion , 2006, Cell.

[211]  M. Zeviani,et al.  The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.

[212]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[213]  Dt Brown,et al.  Transmission of mitochondrial DNA disorders: possibilities for the future , 2006, The Lancet.

[214]  D. Samuels.  Mitochondrial AZT metabolism , 2006, IUBMB life.

[215]  M. C. Leske,et al.  Evaluation of the association between OPA1 polymorphisms and primary open-angle glaucoma in Barbados families. , 2006, Molecular vision.

[216]  G. Diez-Roux,et al.  Optineurin Increases Cell Survival and Translocates to the Nucleus in a Rab8-dependent Manner upon an Apoptotic Stimulus* , 2006, Journal of Biological Chemistry.

[217]  Robert W. Taylor,et al.  Mutant POLG2 Disrupts DNA Polymerase γ Subunits and Causes Progressive External Ophthalmoplegia , 2006 .

[218]  V. Mils,et al.  Mitochondrial dynamics and disease, OPA1. , 2006, Biochimica et biophysica acta.

[219]  L. Van Haute,et al.  Linezolid-induced inhibition of mitochondrial protein synthesis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[220]  Massimo Zeviani,et al.  Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. , 2006, American journal of human genetics.

[221]  L. Balcer.  Clinical practice. Optic neuritis. , 2006, The New England journal of medicine.

[222]  Richard Wormald,et al.  Leading causes of certification for blindness and partial sight in England & Wales , 2006, BMC public health.

[223]  Laura C. Greaves,et al.  Mitochondrial DNA mutations in human disease , 2006, IUBMB life.

[224]  Janet C. Rucker,et al.  Linezolid-associated toxic optic neuropathy , 2006, Neurology.

[225]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[226]  F. Baas,et al.  Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2 , 2006, Annals of neurology.

[227]  V. Carelli,et al.  Colour vision defects in asymptomatic carriers of the Leber’s hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study , 2006, British Journal of Ophthalmology.

[228]  L. Sandvik,et al.  Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV‐1‐infected treatment‐naïve patients , 2006, HIV medicine.

[229]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. , 2006, Brain : a journal of neurology.

[230]  Maastricht.  Influence of mutation type on clinical expression of Leber hereditary optic neuropathy , 2006 .

[231]  U. Inserm.  OPA1 R445H mutation in optic atrophy associated with sensorineural deafness , 2006 .

[232]  R. Sergott.  Optic Neuropathy Associated With Linezolid Treatment , 2006 .

[233]  Robert W. Taylor,et al.  Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. , 2006, American journal of human genetics.

[234]  D. Turnbull,et al.  Treatment for mitochondrial disorders. , 2006, The Cochrane database of systematic reviews.

[235]  S. Züchner,et al.  Mechanisms of Disease: a molecular genetic update on hereditary axonal neuropathies , 2006, Nature Clinical Practice Neurology.

[236]  E. Sutter,et al.  Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. , 2006, Transactions of the American Ophthalmological Society.

[237]  O. Mimura,et al.  Leber's Hereditary Optic Neuropathy Precipitated by Ethambutol , 2006, Japanese Journal of Ophthalmology.

[238]  B. Wissinger,et al.  Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene , 2006, Human Genetics.

[239]  I. D. de Coo,et al.  Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. , 2005, American journal of human genetics.

[240]  N. Newman,et al.  The role of the ND5 gene in LHON: Characterization of a new, heteroplasmic LHON mutation , 2005, Annals of neurology.

[241]  G. Lenaers,et al.  Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network. , 2005, Investigative ophthalmology & visual science.

[242]  M. T. Bhatti,et al.  Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. , 2005, American journal of ophthalmology.

[243]  Michael G Anderson,et al.  Complex genetics of glaucoma susceptibility. , 2005, Annual review of genomics and human genetics.

[244]  F. Bernier,et al.  Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition , 2005, Journal of Medical Genetics.

[245]  L. Osipova,et al.  A novel mtDNA ND6 gene mutation associated with LHON in a Caucasian family. , 2005, Biochemical and biophysical research communications.

[246]  E. Sankila,et al.  Dominant optic atrophy: correlation between clinical and molecular genetic studies. , 2005, Acta ophthalmologica Scandinavica.

[247]  M. Wakakura,et al.  Linezolid-induced optic neuropathy. , 2005, American journal of ophthalmology.

[248]  A. Arnold,et al.  Evolving management of optic neuritis and multiple sclerosis. , 2005, American journal of ophthalmology.

[249]  M. Palacín,et al.  The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. , 2005, Human molecular genetics.

[250]  S. Bhattacharya,et al.  Lack of Association of IVS8+4 C/T and IVS8+32 T/C Polymorphisms in the OPA1 Gene With Normal Tension Glaucoma in Patients From Singapore, India and Japan , 2005 .

[251]  P. Amati‐Bonneau,et al.  eOPA1: An online database for OPA1 mutations , 2005, Human mutation.

[252]  Robert W. Taylor,et al.  LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation , 2005, European Journal of Human Genetics.

[253]  A. Schapira,et al.  Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. , 2005, Archives of neurology.

[254]  C. Wolf,et al.  Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. , 2005, Molecular vision.

[255]  T. Rouault,et al.  Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.

[256]  R. Foroozan,et al.  Optic neuropathy associated with linezolid treatment. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[257]  Elena Bisetto,et al.  Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy , 2005, The FEBS journal.

[258]  E. Boekema,et al.  Structure of a mitochondrial supercomplex formed by respiratory-chain complexes I and III. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[259]  D. Zee,et al.  The neuro-ophthalmology of multiple sclerosis , 2005, The Lancet Neurology.

[260]  R. T. Hart,et al.  The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage , 2005, Progress in Retinal and Eye Research.

[261]  A. Munnich,et al.  A third locus for dominant optic atrophy on chromosome 22q , 2005, Journal of Medical Genetics.

[262]  H. Budka,et al.  Neuropathology of white matter disease in Leber's hereditary optic neuropathy. , 2004, Brain : a journal of neurology.

[263]  A. Schaefer,et al.  Ocular motility findings in chronic progressive external ophthalmoplegia , 2003, Eye.

[264]  S. Kemp,et al.  No evidence for ‘skewed’ inactivation of the X-chromosome as cause of Leber's hereditary optic neuropathy in female carriers , 1996, Human Genetics.

[265]  K. Huoponen,et al.  The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy , 1993, Human Genetics.

[266]  G. Savini,et al.  Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. , 2005, Ophthalmology.

[267]  G. Savini,et al.  Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. , 2005, Ophthalmology.

[268]  S. Bette,et al.  OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain , 2005, Acta Neuropathologica.

[269]  M. Huynen,et al.  Shaping the mitochondrial proteome. , 2004, Biochimica et biophysica acta.

[270]  Dong Myung Kim,et al.  Investigation of the Association between OPA1 Polymorphisms and Normal-Tension Glaucoma in Korea , 2004, Journal of glaucoma.

[271]  B. Barbiroli,et al.  Deficit of in vivo mitochondrial ATP production in OPA1‐related dominant optic atrophy , 2004 .

[272]  B. Barbiroli,et al.  The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy , 2004 .

[273]  Yu Zhao,et al.  Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. , 2004, American journal of ophthalmology.

[274]  J. Morgan,et al.  Circulation and axonal transport in the optic nerve , 2004, Eye.

[275]  H. Kalbacher,et al.  OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina. , 2004, Investigative ophthalmology & visual science.

[276]  A. Schapira,et al.  Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. , 2004, Brain : a journal of neurology.

[277]  Li Guo,et al.  Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[278]  P. Calvas,et al.  OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract , 2004, Journal of Medical Genetics.

[279]  W. Hauswirth,et al.  SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I , 2004, Annals of neurology.

[280]  S. Mallal,et al.  Complications Associated with Nrti Therapy: Update on Clinical Features and Possible Pathogenic Mechanisms , 2004, Antiviral therapy.

[281]  A. Martinuzzi,et al.  Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. , 2004, Biochimica et biophysica acta.

[282]  B. Lam,et al.  Erythromycin as a potential precipitating agent in the onset of Leber's hereditary optic neuropathy. , 2004, Mitochondrion.

[283]  Yau-Huei Wei,et al.  Increased 8-hydroxy-2'-deoxyguanosine in leukocyte DNA in Leber's hereditary optic neuropathy. , 2004, Investigative ophthalmology & visual science.

[284]  S. Bhattacharya,et al.  Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. , 2004, Investigative ophthalmology & visual science.

[285]  C. van Broeckhoven,et al.  Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA. , 2004, Nucleic acids research.

[286]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[287]  N. Wood,et al.  A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. , 2004, Brain : a journal of neurology.

[288]  Robert W. Taylor,et al.  The diagnosis of mitochondrial muscle disease , 2004, Neuromuscular Disorders.

[289]  V. Carelli,et al.  Visual Electrophysiologic Findings in Patients From an Extensive Brazilian Family with Leber's Hereditary Optic Neuropathy Visual electrophysiology in LHON , 2004, Documenta Ophthalmologica.

[290]  A. Munnich,et al.  Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial , 2004, Neurology.

[291]  C. Tifft,et al.  Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation , 2004, American journal of medical genetics. Part A.

[292]  M. Tarnopolsky,et al.  Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation , 2004, American journal of medical genetics. Part A.

[293]  V. Carelli,et al.  Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.

[294]  D. Turnbull,et al.  The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head , 2004, British Journal of Ophthalmology.

[295]  Sequence analysis of Hungarian LHON patients not carrying the common primary mutations , 2002, Journal of Inherited Metabolic Disease.

[296]  N. Newman,et al.  Hereditary optic neuropathies. , 1995, Seminars in ophthalmology.

[297]  A. Harding,et al.  Sequence of the human homologue of a mitochondrially encoded murine transplantation antigen in patients with multiple sclerosis , 1995, Journal of Neurology.

[298]  H. van Jaarsveld,et al.  Exposure of rats to low concentration of cigarette smoke increases myocardial sensitivity to ischaemia/reperfusion , 1992, Basic Research in Cardiology.

[299]  J. Smeitink,et al.  Function and dysfunction of the oxidative phosphorylation system , 2004 .

[300]  J. Zajicek,et al.  The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[301]  A. Martinuzzi,et al.  Apoptotic Cell Death of Cybrid Cells Bearing Leber's Hereditary Optic Neuropathy Mutations Is Caspase Independent , 2003, Annals of the New York Academy of Sciences.

[302]  L. Pasquier,et al.  The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. , 2003, American journal of ophthalmology.

[303]  A. Munnich,et al.  A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q , 2003, European Journal of Human Genetics.

[304]  A. Melamud,et al.  Ocular ethambutol toxicity. , 2003, Mayo Clinic proceedings.

[305]  N. Bresolin,et al.  Remarkable infidelity of polymerase γA associated with mutations in POLG1 exonuclease domain , 2003, Neurology.

[306]  C. Inglehearn,et al.  Polymorphisms in OPA1 are associated with normal tension glaucoma. , 2003, Molecular vision.

[307]  R. Vale,et al.  Mitochondrial positioning in fission yeast is driven by association with dynamic microtubules and mitotic spindle poles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[308]  M. Hennerici,et al.  Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. , 2003, Brain : a journal of neurology.

[309]  V. Carelli,et al.  Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. , 2003, American journal of ophthalmology.

[310]  D. Turnbull,et al.  Frequency of rare mitochondrial DNA mutations in patients with suspected Leber’s hereditary optic neuropathy , 2003, Journal of medical genetics.

[311]  S. Dimauro,et al.  Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.

[312]  M. Hirano,et al.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. , 2003, The Journal of clinical investigation.

[313]  F. Rolling,et al.  Sustained tetracycline‐regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno‐associated viral vector , 2003, The journal of gene medicine.

[314]  A. Arnold.  Pathogenesis of nonarteritic anterior ischemic optic neuropathy. , 2003, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[315]  D. Mackey,et al.  Sequence analysis of the mitochondrial genomes from Dutch pedigrees with Leber hereditary optic neuropathy. , 2003, American journal of human genetics.

[316]  S. di Donato,et al.  Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial , 2003, Neurology.

[317]  E. Shink,et al.  Lack of Association between Normal-tension Glaucoma and Intron 8 Polymorphisms in the Gene Causing Autosomal Dominant Optic Atrophy, OPA1, in Japan , 2003 .

[318]  J. B. Tok,et al.  Aminoglycoside and its derivatives as ligands to target the ribosome. , 2003, Current topics in medicinal chemistry.

[319]  R. Lai,et al.  Role of alpha-2 agonists in neuroprotection. , 2003, Survey of ophthalmology.

[320]  A. Schapira,et al.  Leber's Hereditary Optic Neuropathy (LHON) Pathogenic Mutations Induce Mitochondrial-dependent Apoptotic Death in Transmitochondrial Cells Incubated with Galactose Medium* , 2003, The Journal of Biological Chemistry.

[321]  D. Turnbull,et al.  The epidemiology of Leber hereditary optic neuropathy in the North East of England. , 2003, American journal of human genetics.

[322]  W. Hauswirth,et al.  Suppression of complex I gene expression induces optic neuropathy , 2003, Annals of neurology.

[323]  S. Shimizu,et al.  A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy. , 2003, American journal of ophthalmology.

[324]  E. Reid,et al.  Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias , 2003, Journal of medical genetics.

[325]  S. Bhattacharya,et al.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy , 2003, The British journal of ophthalmology.

[326]  D. Mackey,et al.  Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus , 2003, Eye.

[327]  S. Park,et al.  Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy , 2003, Journal of Neurology.

[328]  K. Dingemans,et al.  Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. , 2002, The New England journal of medicine.

[329]  R. Sergott,et al.  Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. , 2002, Current opinion in ophthalmology.

[330]  B. Katz.  Disc excavation in dominant optic atrophy. , 2002, Ophthalmology.

[331]  D. Besch,et al.  Leber’s hereditary optic neuropathy: clinical and molecular genetic results in a patient with a point mutation at np T11253C (isoleucine to threonine) in the ND4 gene and spontaneous recovery , 2002, Graefe’s Archive for Clinical and Experimental Ophthalmology.

[332]  D. Mackey,et al.  Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease , 2002, Journal of medical genetics.

[333]  Robert W. Taylor,et al.  Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. , 2002, Nucleic acids research.

[334]  D. Besch,et al.  Sequence analysis of the complete mitochondrial genome in patients with Leber's hereditary optic neuropathy lacking the three most common pathogenic DNA mutations. , 2002, Biochemical and biophysical research communications.

[335]  F. Gonzalez-Lima,et al.  Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction , 2002, Neuroscience Letters.

[336]  A. Torroni,et al.  Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber's hereditary optic neuropathy , 2002, Annals of neurology.

[337]  Michael E Shy,et al.  Hereditary motor and sensory neuropathies: a biological perspective , 2002, The Lancet Neurology.

[338]  Margaret A. Johnson,et al.  The distribution of mitochondrial activity in relation to optic nerve structure. , 2002, Archives of ophthalmology.

[339]  B. Barbiroli,et al.  Phosphorus MR spectroscopy shows a tissue specific in vivo distribution of biochemical expression of the G3460A mutation in Leber's hereditary optic neuropathy , 2002, Journal of neurology, neurosurgery, and psychiatry.

[340]  A. Munnich,et al.  Molecular insights into Friedreich's ataxia and antioxidant-based therapies. , 2002, Trends in molecular medicine.

[341]  S. Park,et al.  Mitochondrial DNA C4171A/ND1 is a novel primary causative mutation of Leber's hereditary optic neuropathy with a good prognosis , 2002, Annals of neurology.

[342]  D. Turnbull,et al.  Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. , 2002, American journal of human genetics.

[343]  K. Khrapko,et al.  Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[344]  P. Harrigan,et al.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. , 2002, The New England journal of medicine.

[345]  E. Schon,et al.  Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus , 2002, Nature Genetics.

[346]  M. Seldin,et al.  Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. , 2002, Human molecular genetics.

[347]  R. Ritch,et al.  Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin , 2002, Science.

[348]  D. Besch,et al.  Confirmation of the 14568 mutation in the mitochondrial ND6 gene as causative in Leber's hereditary optic neuropathy , 2002, Ophthalmic genetics.

[349]  P. Chinnery.  Modulating heteroplasmy. , 2002, Trends in genetics : TIG.

[350]  Yau-Huei Wei,et al.  Leber's hereditary optic neuropathy--the spectrum of mitochondrial DNA mutations in Chinese patients. , 2002, Japanese journal of ophthalmology.

[351]  E. Starikovskaya,et al.  The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J , 2002, Human Genetics.

[352]  W. Gahl,et al.  Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. , 2001, American journal of human genetics.

[353]  M. Krawczak,et al.  A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene , 2001, Human Genetics.

[354]  Masasuke Yoshida,et al.  ATP synthase — a marvellous rotary engine of the cell , 2001, Nature Reviews Molecular Cell Biology.

[355]  D. Epstein,et al.  Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma. , 2001, Ophthalmology.

[356]  M. Marinis.  Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation , 2001, Journal of Neurology.

[357]  G. Comi,et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria , 2001, Nature Genetics.

[358]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[359]  N. Newman,et al.  Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families , 2001, Human Genetics.

[360]  D. Mackey,et al.  Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. , 2001, Human molecular genetics.

[361]  E. Zrenner,et al.  OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. , 2001, Human molecular genetics.

[362]  H. Ujike,et al.  A family with X-linked dystonia-deafness syndrome with a novel mutation of the DDP gene. , 2001, Archives of neurology.

[363]  M. Rovaris,et al.  Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[364]  K. Yarasheski,et al.  Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[365]  R. Cann.  Genetic Clues to Dispersal in Human Populations: Retracing the Past from the Present , 2001, Science.

[366]  P. Klivényi,et al.  α-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation , 2001, Journal of neurology, neurosurgery, and psychiatry.

[367]  M. Votruba,et al.  The pupil in dominant optic atrophy. , 2001, Investigative ophthalmology & visual science.

[368]  D. Turnbull,et al.  Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? , 2001, American journal of medical genetics.

[369]  E. Sapey,et al.  Evidence of active demyelination in a man with Leber's hereditary optic neuropathy mtDNA 14484 genotype , 2001 .

[370]  Yin Chang,et al.  The spatial distribution of macular pigment in humans , 2001, Current eye research.

[371]  K. Skullerud,et al.  Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene , 2001, Ophthalmic genetics.

[372]  R. Bone,et al.  Lutein, zeaxanthin, and the macular pigment. , 2001, Archives of biochemistry and biophysics.

[373]  D. Turnbull,et al.  The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. , 2001, Brain : a journal of neurology.

[374]  S. Mansour,et al.  Leber hereditary optic neuropathy associated with antiretroviral therapy for human immunodeficiency virus infection. , 2001, American journal of ophthalmology.

[375]  D. Wallace,et al.  Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation* , 2000, The Journal of Biological Chemistry.

[376]  T. Beaty,et al.  A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. , 2000, American journal of ophthalmology.

[377]  D. Turnbull,et al.  The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? , 2000, Trends in genetics : TIG.

[378]  J. Lanciego,et al.  Current concepts in neuroanatomical tracing , 2000, Progress in Neurobiology.

[379]  C. Westfall,et al.  Chronic exposure keratopathy complicating surgical correction of ptosis in patients with chronic progressive external ophthalmoplegia. , 2000, American journal of ophthalmology.

[380]  B. Robinson,et al.  Mitochondria, oxygen free radicals, disease and ageing. , 2000, Trends in biochemical sciences.

[381]  P. Venegas-Francke,et al.  [Bilateral optic neuritis caused by chloramphenicol]. , 2000, Revista de neurologia.

[382]  J. Grosgeorge,et al.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.

[383]  S. Bhattacharya,et al.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.

[384]  M. Wakakura,et al.  Do Idebenone and Vitamin Therapy Shorten the Time to Achieve Visual Recovery in Leber Hereditary Optic Neuropathy? , 2000, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[385]  B. Barbiroli,et al.  'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. , 2000, Brain : a journal of neurology.

[386]  L. Peltonen,et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. , 2000, Science.

[387]  T G Frey,et al.  The internal structure of mitochondria. , 2000, Trends in biochemical sciences.

[388]  P. Donnelly,et al.  The mutation rate in the human mtDNA control region. , 2000, American journal of human genetics.

[389]  T. Friedmann,et al.  Principles for Human Gene Therapy Studies , 2000, Science.

[390]  T. Friedmann.  Medical ethics. Principles for human gene therapy studies. , 2000, Science.

[391]  P. Win,et al.  Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. , 2000, Transactions of the American Ophthalmological Society.

[392]  F. Meire,et al.  Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis , 2000, Journal of Neurology.

[393]  A. Gerinec,et al.  [Leber's hereditary optic neuropathy]. , 1999, Casopis lekaru ceskych.

[394]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[395]  D. Turnbull,et al.  Nonrandom tissue distribution of mutant mtDNA. , 1999, American journal of medical genetics.

[396]  E. Zrenner,et al.  Leber’s hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[397]  A. Munnich,et al.  Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.

[398]  M. Vagefi,et al.  Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3. , 1999, Archives of ophthalmology.

[399]  D. Johns,et al.  Smoking as an aetiological factor in a pedigree with Leber’s hereditary optic neuropathy , 1999, British Journal of Ophthalmology.

[400]  J. Cooper,et al.  Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy , 1999, Journal of the Neurological Sciences.

[401]  Margaret A. Johnson,et al.  Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina , 1999, The British journal of ophthalmology.

[402]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[403]  B. Lang,et al.  Mitochondrial evolution. , 1999, Science.

[404]  L. Levin,et al.  Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. , 1999, Investigative ophthalmology & visual science.

[405]  B F Lang,et al.  Mitochondrial evolution. , 1999, Science.

[406]  D. Mackey,et al.  Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy. , 1998, American journal of human genetics.

[407]  Douglas R. Anderson,et al.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.

[408]  M. Votruba,et al.  Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. , 1998, Journal of medical genetics.

[409]  Douglas R. Anderson,et al.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.

[410]  S. Tabrizi,et al.  The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy , 1998, Annals of neurology.

[411]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[412]  S. Lessell.  Nutritional Amblyopia , 1998, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[413]  A. Federico,et al.  A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778 , 1998, Journal of Neurology.

[414]  N. Shimizu,et al.  Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy. , 1998, Current eye research.

[415]  W. Martin,et al.  The hydrogen hypothesis for the first eukaryote , 1998, Nature.

[416]  F. Fitzke,et al.  Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. , 1998, Archives of ophthalmology.

[417]  M. Stoneking,et al.  Mitochondrial mutation rate revisited: hot spots and polymorphism , 1998, Nature Genetics.

[418]  D. Turnbull,et al.  Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. , 1997, Trends in genetics : TIG.

[419]  F. Riemslag,et al.  A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. , 1997, American journal of human genetics.

[420]  N. Newman,et al.  De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber's hereditary optic neuropathy , 1997, Neurology.

[421]  G. Radda,et al.  In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.

[422]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[423]  M. Araie,et al.  Intraocular pressure and central visual field of normal tension glaucoma , 1997, The British journal of ophthalmology.

[424]  S J Young,et al.  Electron tomography of neuronal mitochondria: three-dimensional structure and organization of cristae and membrane contacts. , 1997, Journal of structural biology.

[425]  P. Cortelli,et al.  Leber's hereditary optic neuropathy , 1997, Neurology.

[426]  E. Zrenner,et al.  Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy. , 1997, Biochemical and biophysical research communications.

[427]  P. Zaniol,et al.  Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study , 1997, Journal of the Neurological Sciences.

[428]  Mark R. Wilson,et al.  A high observed substitution rate in the human mitochondrial DNA control region , 1997, Nature Genetics.

[429]  R. Tomsak,et al.  Nutritional deficiency amblyopia or Leber's hereditary optic neuropathy? , 1997 .

[430]  H. Lubs,et al.  Full-field electroretinograms in a family with Mohr-Tranebjaerg syndrome. , 2009, Acta ophthalmologica Scandinavica.

[431]  T. Rosenberg,et al.  Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. , 2009, Acta ophthalmologica Scandinavica.

[432]  Y. Mashima,et al.  High incidence of pre‐excitation syndrome in Japanese families with Leber's hereditary optic neuropathy , 1996, Clinical genetics.

[433]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[434]  A. Harding,et al.  A case-control study of Leber's hereditary optic neuropathy. , 1996, Brain : a journal of neurology.

[435]  D. Mackey,et al.  How rapidly does the human mitochondrial genome evolve? , 1996, American journal of human genetics.

[436]  D. Mackey,et al.  Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. , 1996, American journal of human genetics.

[437]  M. Finel,et al.  Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy. , 1996, European journal of biochemistry.

[438]  G. Hofhaus,et al.  Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic Neuropathy* , 1996, The Journal of Biological Chemistry.

[439]  G. Bruyn,et al.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. , 1996, American journal of human genetics.

[440]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[441]  K. Huoponen,et al.  Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. , 1996, Ophthalmology.

[442]  E. Hoffman,et al.  X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant. , 1996, American journal of medical genetics.

[443]  M. Knaap,et al.  Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings , 1996, Journal of the Neurological Sciences.

[444]  J. Cooper,et al.  The 14484 ND6 mtDNA mutation in Leber hereditary optic neuropathy does not affect fibroblast complex I activity. , 1995, American journal of human genetics.

[445]  Cuba Neuropathy Field Investigation Team.  Epidemic optic neuropathy in Cuba--clinical characterization and risk factors. , 1995, The New England journal of medicine.

[446]  E. Bleeker-Wagemakers,et al.  The mitochondrial DNA mutation ND6*14,484C associated with leber hereditary optic neuropathy, leads to deficiency of complex I of the respiratory chain. , 1995, Biochemical and biophysical research communications.

[447]  J. Martín,et al.  Neurological disorders in members of families with Leber's hereditary optic neuropathy (LHON) caused by different mitochondrial mutations. , 1995, Ophthalmic genetics.

[448]  K. Huoponen,et al.  Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[449]  A. Harding,et al.  Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. , 1995, American journal of human genetics.

[450]  P. Zaniol,et al.  Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation , 1995, Neurology.

[451]  R. Carrozzo,et al.  MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. , 1995, Biochemical and biophysical research communications.

[452]  M. Wikström,et al.  A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy. , 1995, American journal of human genetics.

[453]  G. Plazzi,et al.  Abnormal lactate after effort in healthy carriers of Leber's hereditary optic neuropathy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[454]  M. Wakakura,et al.  Evidence for preserved direct pupillary light response in Leber's hereditary optic neuropathy. , 1995, The British journal of ophthalmology.

[455]  R. Stevenson,et al.  A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. , 1995, Journal of medical genetics.

[456]  A. Harding,et al.  Mitochondrial DNA diseases: Genotype and phenotype in leber's hereditary optic neuropathy , 1995, Muscle & nerve. Supplement.

[457]  A. Torroni,et al.  Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations , 1995, Human mutation.

[458]  P. Cortelli,et al.  Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy , 1994, FEBS letters.

[459]  K. Huoponen,et al.  Pre-excitation syndrome in Leber's hereditary optic neuropathy , 1994, The Lancet.

[460]  N. Newman,et al.  Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's hereditary optic neuropathy patients. Cuba Neuropathy Field Investigation Team. , 1994, American journal of ophthalmology.

[461]  A. Harding,et al.  Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis , 1994, Annals of neurology.

[462]  D. Wallace,et al.  A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[463]  A. Torroni,et al.  Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance , 1994, Journal of bioenergetics and biomembranes.

[464]  A. Sadun,et al.  Epidemic optic neuropathy in Cuba. Eye findings. , 1994, Archives of ophthalmology.

[465]  J. Cooper,et al.  Platelet mitochondrial function in Leber's hereditary optic neuropathy , 1994, Journal of the Neurological Sciences.

[466]  R. Beck,et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.

[467]  N. Miller,et al.  Identical twins who are discordant for Leber's hereditary optic neuropathy. , 1993, Archives of ophthalmology.

[468]  N. Miller,et al.  Heteroplasmy in Leber's hereditary optic neuropathy. , 1993, Archives of ophthalmology.

[469]  N. Miller,et al.  Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. , 1993, Archives of ophthalmology.

[470]  D. Johns,et al.  Cytochrome c oxidase mutations in Leber hereditary optic neuropathy. , 1993, Biochemical and biophysical research communications.

[471]  N. Howell,et al.  When does bilateral optic atrophy become Leber hereditary optic neuropathy? , 1993, American journal of human genetics.

[472]  D. Eliott,et al.  Visual prognosis in autosomal dominant optic atrophy (Kjer type). , 1993, American journal of ophthalmology.

[473]  N. Miller,et al.  Leber's hereditary optic neu-ropathy. Clinical manifestations of the 14484 mutation , 1993 .

[474]  J. Rizzo,et al.  Tobacco amblyopia. , 1993, American journal of ophthalmology.

[475]  D. Mackey,et al.  A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. , 1992, American journal of human genetics.

[476]  M. Beal,et al.  Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age , 1992, Nature Genetics.

[477]  D R Johns,et al.  An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. , 1992, Biochemical and biophysical research communications.

[478]  J. Rotter,et al.  Leber hereditary optic neuropathy: estimation of number of embryonic precursor cells and disease threshold in heterozygous affected females at the X‐linked locus , 1992, Clinical genetics.

[479]  W. Mcdonald,et al.  Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. , 1992, Brain : a journal of neurology.

[480]  D. Mackey,et al.  Leber hereditary optic neuropathy in Australia. , 1992, Australian and New Zealand journal of ophthalmology.

[481]  D. Mackey,et al.  Cardiac arrhythmia and Leber's hereditary optic neuropathy , 1992, The Lancet.

[482]  N. Newman,et al.  Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. , 1992, Journal of clinical neuro-ophthalmology.

[483]  M. Wikström,et al.  Electron transfer properties of NADH: Ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON) , 1991, FEBS letters.

[484]  E. Holme,et al.  Leber's hereditary optic neuropathy and complex I deficiency in muscle , 1991, Annals of neurology.

[485]  D. Turnbull,et al.  Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. , 1991, American journal of human genetics.

[486]  J. Rotter,et al.  X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[487]  K. Huoponen,et al.  A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. , 1991, American journal of human genetics.

[488]  N. Howell,et al.  Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. , 1991, American journal of human genetics.

[489]  H. Krastel,et al.  Electrophysiology and colour perimetry in dominant infantile optic atrophy. , 1991, The British journal of ophthalmology.

[490]  E. Shoubridge,et al.  Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease , 1990, Cell.

[491]  H. Yonekawa,et al.  Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.

[492]  Yunis Aa.  Chloramphenicol toxicity: 25 years of research. , 1989 .

[493]  J. Parks,et al.  A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. , 1989, The New England journal of medicine.

[494]  N. Gadoth,et al.  A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia , 1989, Neurology.

[495]  A. Yunis.  Chloramphenicol toxicity: 25 years of research. , 1989, The American journal of medicine.

[496]  D. Wallace,et al.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. , 1988, Science.

[497]  J. Kucharská,et al.  The effect of smoking on myocardial metabolism. , 1987, Czechoslovak medicine.

[498]  R. Goldberg,et al.  Management of Ptosis in Chronic Progressive External Ophthalmoplegia , 1987, Ophthalmic plastic and reconstructive surgery.

[499]  F. Meire,et al.  Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO). , 1985, Ophthalmic paediatrics and genetics.

[500]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[501]  N. Avadhani,et al.  The complexity of mitochondrial translation products in mammalian cells. , 1981, Biochemical and biophysical research communications.

[502]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[503]  M. Lazar,et al.  Chloramphenicol optic neuropathy. , 1980, Archives of ophthalmology.

[504]  J. Herschler,et al.  Nonglaucomatous excavation of the optic disc. , 1980, Archives of ophthalmology.

[505]  C. Hoyt,et al.  Autosomal dominant optic atrophy. A spectrum of disability. , 1980, Ophthalmology.

[506]  L. Kline,et al.  Dominant optic atrophy. The clinical profile. , 1979, Archives of ophthalmology.

[507]  L. Dorfman,et al.  The early phase in Leber hereditary optic atrophy. , 1977, Archives of ophthalmology.

[508]  F. N. Ghadially,et al.  Chloramphenicol-induced mitochondrial and ultrastructural changes in hemopoietic cells. , 1976, Archives of pathology & laboratory medicine.

[509]  D. Cogan,et al.  Optic neuropathy, chloramphenicol, and infantile genetic agranulocytosis. , 1973, Investigative ophthalmology.

[510]  L Margulis,et al.  Symbiosis and evolution. , 1971, Scientific American.

[511]  A. Yunis,et al.  Chloramphenicol-related changes in mitochondrial ultrastructure. , 1970, Journal of cell science.

[512]  A. Yunis,et al.  Reversible bone marrow suppression from chloramphenicol. A consequence of mitochondrial injury. , 1970, Archives of internal medicine.

[513]  D. Y. Thomas,et al.  Inhibition of mitochondrial synthesis in yeast by erythromycin: cytoplasmic and nuclear factors controlling resistance. , 1968, Genetical research.

[514]  Pask Ea,et al.  HOMOSEXUALITY AS A CRIME. , 1965 .

[515]  P. Kjer.  Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. , 1959, Acta ophthalmologica. Supplementum.

[516]  P. Kjer.  Hereditary infantile optic atrophy with dominant transmission. , 1957, Acta genetica et statistica medica.

[517]  P. Kjer.  Hereditary infantile optic atrophy with dominant transmission; preliminary report. , 1956, Danish medical bulletin.